Showing Results for
- Academic Journals (15)
Search Results
- 15
Academic Journals
- 15
-
From:Future Oncology (Vol. 11, Issue 12) Peer-ReviewedAuthor(s): Manali I Patel aff1 , Kim F Rhoads [*] aff2 KEYWORDS cancer; disparities; evidence-based care; health equity Historical explanations for disparities: are we running in place or falling behind?...
-
From:Future Oncology (Vol. 11, Issue 12) Peer-ReviewedAuthor(s): Guanqiao Li aff1 , Xiaojie Zhong aff1 , Jia Yao aff1 , Jimin Chen aff2 , Mei Wang aff1 , Haiying Liu aff1 , Shiping Yang [*] aff3 KEYWORDS breast; clinical feature; male; secretory carcinoma; treatment...
-
From:Future Oncology (Vol. 11, Issue 12) Peer-ReviewedAuthor(s): Qian Li aff1 , Rongyuan Zhuang aff1 , Jun Zhu aff2 , Weiqi Lu aff2 , Yingyong Hou aff3 , Ju Liu aff3 , Yong Zhang aff2 , Yan Wang aff1 , Tianshu Liu aff1 , Zhiming Wang aff1 , Yuhong Zhou [*] aff1 KEYWORDS...
-
From:Future Oncology (Vol. 11, Issue 12) Peer-ReviewedAuthor(s): Loredana Lorusso aff1 , Kate Newbold [*] aff1 KEYWORDS E7080; lenvatinib; thyroid cancer; tyrosine kinase inhibitor treatment Thyroid cancer is the most common endocrine neoplasia and it represents...
-
From:Future Oncology (Vol. 11, Issue 12) Peer-ReviewedAuthor(s): Guy Jerusalem [*] aff1 , Andrée Rorive aff2 , Joëlle Collignon aff2 KEYWORDS capecitabine; chemotherapy; eribulin; etirinotecan pegol; gemcitabine; irinotecan; ixabepilone; metastatic breast cancer;...
-
From:Future Oncology (Vol. 11, Issue 12) Peer-ReviewedAuthor(s): Silvia Ortolani aff1 , Chiara Ciccarese aff1 , Sara Cingarlini aff1 , Giampaolo Tortora aff1 , Francesco Massari [*] aff1 KEYWORDS everolimus; mTOR inhibitors; mTOR pathway; neuroendocrine neoplasm;...
-
From:Future Oncology (Vol. 11, Issue 12) Peer-ReviewedFollowing publication of the Research Article by Orazio Caffo, Giovanni Lo Re, Teodoro Sava, Sebastiano Buti, Cosimo Sacco, Umberto Basso, Fable Zustovich, Michele Lodde, Alessandra Perin, Gaetano Facchini, Antonello...
-
From:Future Oncology (Vol. 11, Issue 12) Peer-ReviewedAuthor(s): Ruty Mehrian-Shai [*] aff1 , Shany Freedman aff1 , Soheil Shams aff2 , Joni Doherty aff3 , William Slattery aff4 , Nancy Ya-Hsuan Hsu aff5 , Juergen KV Reichardt aff6 , Ali Andalibi aff7 , Amos Toren aff1...
-
From:Future Oncology (Vol. 11, Issue 12) Peer-ReviewedAuthor(s): Moshe Frenkel [*] aff1 aff2 , Sky Gross aff3 , Ariela Popper Giveon aff4 , Kenneth Sapire aff5 , Doron Hermoni aff6 KEYWORDS alternative medicine; cancer care; cancer survival; complementary medicine;...
-
From:Future Oncology (Vol. 11, Issue 12) Peer-ReviewedAuthor(s): Wenhao Weng aff1 , Junlan Feng aff2 , Huanlong Qin aff3 , Yanlei Ma aff3 , Ajay Goel [*] aff4 KEYWORDS carcinogenesis; clinical application; colorectal cancer; diagnosis; miRNA; predictive biomarkers;...
-
From:Future Oncology (Vol. 11, Issue 12) Peer-ReviewedAuthor(s): Naresh Bumma aff1 , Nikolaos Papadantonakis aff2 , Anjali S Advani [*] aff2 KEYWORDS acute lymphoblastic leukemia; bispecific antibody; blinatumomab; minimal residual disease; relapse The incidence...
-
From:Future Oncology (Vol. 11, Issue 12) Peer-ReviewedAuthor(s): Colin Watts [*] KEYWORDS brain; cancer; cancer stem cells; clinical trials; evolution; genomics; glioblastoma; sampling bias; therapy Glioblastoma (GBM), the most common primary brain cancer, is...
-
From:Future Oncology (Vol. 11, Issue 12) Peer-ReviewedAuthor(s): Omar Abdel-Rahman [*] aff1 , Mona Fouad aff2 KEYWORDS GIST; imatinib; salvage treatment; second line; systemic treatment; third line Gastrointestinal stromal tumor (GIST) is the most common...
-
From:Future Oncology (Vol. 11, Issue 12) Peer-ReviewedAuthor(s): Donghai Xiong aff1 aff2 , Yian Wang aff1 , Ming You [*] aff1 aff2 KEYWORDS exome sequencing; familial lung cancer; genomics; mutations; PARK2 PARK2 has tumor suppressive role in cancer In general,...
-
From:Future Oncology (Vol. 11, Issue 12) Peer-ReviewedAuthor(s): Heather Payne [*] KEYWORDS advanced prostate cancer; Astellas; Every Moment Matters; Every Voice Matters; prostate cancer; quality of life Q Can you tell our readers about your career to date & what...